Skip to main content

Molecular Diversity in Drug Design

  • Book
  • © 2002

Overview

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (10 chapters)

Keywords

About this book

High-throughput screening and combinatorial chemistry are two of the most potent weapons ever to have been used in the discovery of new drugs. At a stroke, it seems to be possible to synthesise more molecules in a month than have previously been made in the whole of the distinguished history of organic chemistry, Furthermore, all the molecules can be screened in the same short period. However, like any weapons of immense power, these techniques must be used with care, to achieve maximum impact. The costs of implementing and running high-throughput screening and combinatorial chemistry are high, as large dedicated facilities must be built and staffed. In addition, the sheer number of chemical leads generated may overwhelm the lead optimisation teams in a hail of friendly fire. Mother nature has not entirely surrendered, as the number of building blocks that could be used to build libraries would require more atoms than there are in the universe. In addition, the progress made by the Human Genome Project has uncovered many proteins with different functions but related binding sites, creating issues of selectivity. Advances in the new field of pharmacogenomics will produce more of these challenges. There is a real need to make hi- throughput screening and combinatorial chemistry into 'smart' weapons, so that their power is not dissipated. That is the challenge for modellers, computational chemists, cheminformaticians and IT experts. In this book, we have broken down this grand challenge into key tasks.

Reviews

`This excellent work can be recommended unreservedly for natural sciences students in the final of a degree course and for research scientists... The excellent articles by Peter Willett and Jonathan Mason are sufficient reason ... for buying the book. The authors and editors of this book have laid a solid foundation...'
Angewandte Chemie, 39:15 (2000)

Bibliographic Information

  • Book Title: Molecular Diversity in Drug Design

  • Editors: Philip M. Dean, Richard A. Lewis

  • DOI: https://doi.org/10.1007/0-306-46873-5

  • Publisher: Springer Dordrecht

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Science+Business Media Dordrecht 2002

  • Hardcover ISBN: 978-0-7923-5980-7Published: 31 October 1999

  • Softcover ISBN: 978-94-017-3831-6Published: 03 October 2013

  • eBook ISBN: 978-0-306-46873-5Published: 08 May 2007

  • Edition Number: 1

  • Number of Pages: XIV, 254

  • Topics: Computer Applications in Chemistry, Pharmacy, Theoretical and Computational Chemistry

Publish with us